Rating History for Recursion Pharmaceuticals (RXRX) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/17/2025 | Priyanka Grover | Upgrade | Overweight (Neutral) |
11.00 (10.00) |
4.20 (3.46) |
-17.62% | Details |
 |
|||||||
|
|||||||
|
|||||||
